SPERO THERAPEUTICS, INC.
Profile
Company Names
SPERO THERAPEUTICS, INC.
SPERO THERAPEUTICS, LLC
Addresses
675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA 02139
Phone Numbers
857-242-1600
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2013
State Incorporated:
DELAWARE
Total Amount Raised:
$92,177,036.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-11-07
$9,000,000.00
$9,000,000.00
$0.00
Equity
2
2021-06-30
$39,999,985.00
$39,999,985.00
$0.00
Equity
1
2017-03-07
$43,177,051.00
$43,177,051.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
CASPER
BREUM
DIRECTOR
MILIND
DESHPANDE
DIRECTOR
JEAN-FRANCOIS
FORMELA
DIRECTOR
ARCA BIOPHARMA, INC.
| RESOLVYX PHARMACEUTICALS, INC.
| HORIZON PHARMA, INC.
| ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| COSTIM PHARMACEUTICALS INC.
| CALORICS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| INTELLIA THERAPEUTICS, INC.
| IFM THERAPEUTICS, INC.
| SPERO THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| IFM TRE, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| TRANSLATE BIO, INC.
| KORRO BIO, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| ATLAS VENTURE FUND XII, L.P.
| SCORPION THERAPEUTICS, INC.
| SPERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| AMAGMA, INC.
| IKENA ONCOLOGY, INC.
| ANTARES THERAPEUTICS, INC.
VIKAS
GOYAL
DIRECTOR
SCOTT
JACKSON
DIRECTOR
AMERICAN TITANIUM WORKS LLC
| CELATOR PHARMACEUTICALS INC
| COMMUNITY BANK PARTNERS, INC.
| MVCONNECT HOLDINGS, LLC
| OOTI TOURING LLC
| BRONX TOURING LLC
| VESTARON CORP
| SPERO THERAPEUTICS, INC.
| HAIRSPRAY TOURING II LLC
| PROM TOURING LLC
| BOM TOURING LLC
| BEETLEJUICE FIRST NATIONAL TOUR LLC
| CFA TOURING LLC
| FUNNY GIRL FIRST TOURING LLC
| MEAN GIRLS TOURING LLC
ANKIT
MAHADEVIA
EXECUTIVE OFFICER, DIRECTOR
CYNTHIA
SMITH
DIRECTOR
FRANK
E.
THOMAS
DIRECTOR
PATRICK
VINK
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-11-07
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-06-30
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

